Home > Insider Trading > Filing (0000950170-24-083227)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521036	Lantheus Holdings Inc.	LNTH	In Vitro & In Vivo Diagnostic Substances (2835)	352318913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673416	J Gary Pruden	C/O Lantheus Holdings, Inc. 201 Burlington Road, South Building Bedford MA 01730		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-07-10	12,530	$95.04	11,978	No	4	S	Indirect	By the Gary J. Pruden Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By the Gary J. Pruden Revocable Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,635	Direct
Common Stock	8,449	Indirect	By the Georgeane Pruden Revocable Trust

Footnotes

The reporting person and his spouse are trustees of the Georgeane Pruden Revocable Trust, and the reporting person's children are the sole beneficiaries of the trust. The reporting person remains the beneficial owner of the securities held by the trust.
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2023.
The reporting person and his spouse are trustees of the Gary J. Pruden Revocable Trust, and the reporting person's children are the sole beneficiaries of the trust. The reporting person remains the beneficial owner of the securities held by the trust.